Siatis Perry C
SEC CIK 1951400 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | EVP, GC AND Sec | 17.5K | — | $24.22M | 24 | 2023-02-16 | 2026-03-02 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-03 | 2026-03-02 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale | $234.39 | -18.7K | 17.5K | -52% | -$4.38M |
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | F - Tax | $232.08 | -14.8K | 23.3K | -39% | -$3.45M | |
| DM | 2026-02-27 | 2026-02-25 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $172.62 | +22.4K | 53.2K | +73% | +$3.86M |
| D | 2026-02-27 | 2026-02-25 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $230.00 | -22.4K | 38.1K | -37% | -$5.15M |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | A - Grant | $0.00 | +33.5K | 26.7K | New | $0 |
| DM | 2025-03-04 | 2025-02-28+ | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $208.69 | -27.9K | 11.8K | -70% | -$5.82M |
| DM | 2025-03-04 | 2025-03-03 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $159.88 | +18.0K | 14.9K | New | +$2.88M |
| D | 2025-03-04 | 2025-02-28 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | F - Tax | $205.02 | -7,870 | 14.5K | -35% | -$1.61M |
| M | 2025-02-24 | 2025-02-20 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale | $197.90 | -5,778 | 26.4K | -18% | -$1.14M |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | A - Grant | $0.00 | +17.8K | 14.9K | New | $0 |
| M | 2024-03-01 | 2024-02-29 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale | $177.39 | -9,891 | 13.8K | -42% | -$1.75M |
| 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | F - Tax | $178.99 | -7,885 | 20.3K | -28% | -$1.41M | |
| D | 2024-02-27 | 2024-02-23 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $177.51 | -13.8K | 28.2K | -33% | -$2.44M |
| DM | 2024-02-27 | 2024-02-23 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $137.36 | +13.8K | 41.9K | +49% | +$1.89M |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | A - Grant | $0.00 | +17.8K | 18.4K | +2,951% | $0 |
| D | 2024-02-06 | 2024-02-02 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | D - Sale to Iss | $170.00 | -2,919 | 10.4K | -22% | -$496.2K |
| D | 2024-02-06 | 2024-02-02 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | A - Grant | $144.54 | +2,919 | 13.3K | +28% | +$421.9K |
| D | 2023-04-05 | 2023-04-03 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $160.00 | -3,520 | 10.4K | -25% | -$563.2K |
| D | 2023-04-05 | 2023-04-03 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $105.92 | +3,520 | 13.9K | +34% | +$372.8K |
| M | 2023-03-02 | 2023-03-01 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale | $153.08 | -12.1K | 10.4K | -54% | -$1.86M |
| 2023-03-02 | 2023-02-28 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | F - Tax | $154.28 | -9,656 | 22.5K | -30% | -$1.49M | |
| DM | 2023-02-22 | 2023-02-21 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | S - Sale+OE | $151.03 | -7,364 | 32.2K | -19% | -$1.11M |
| D | 2023-02-22 | 2023-02-21 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | M - OptEx | $93.50 | +7,364 | 39.5K | +23% | +$688.5K |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | Siatis Perry C | EVP, GC AND Sec | A - Grant | $0.00 | +21.8K | 30.3K | +255% | $0 |
Purchase Sale Sale after option exercise All abbreviations